Pharmafile Logo

Making a difference to patients with IBD

November 16, 2015 |  

Changing lives with medical education

Lucid Group, together with a group of IBD experts, have developed an online tool to help gastroenterologists use the ulcerative colitis endoscopic index of severity (UCEIS). Lucid hopes that the online tool will help set standards for wider and better use of the UCEIS. Using objective scoring systems like the UCEIS, in a consistent way will help assess patients’ disease severity and guide appropriate treatment.    

The tool development was led by Professor Simon Travis, on behalf of the UCEIS study group, together with Dr Rebecca Palmer of Oxford University Hospitals Foundation Trust.  Speaking about the tool, he said; “Low awareness of endoscopic scoring indices, like the UCEIS, created enormous variation between physicians when assessing a patients disease severity.  Lucid Group have developed a user friendly, robust training tool which all gastroenterologists treating patients with Ulcerative Colitis are encouraged to use, this is hosted on the website of the European Crohn’s and colitis organisation (ECCO).”- PMLiVE

- PMLiVE- PMLiVE
You can read more news from Lucid Group here http://www.lucid-group.co.uk/#!news/c1idu

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

A Stellar Start to 2021 for Lucid Group

It’s been a stellar start to 2021 for Lucid Group, which has welcomed 38 new starters into the company since the beginning of the year. These include 15 Client Services...

Day in a #LucidLife – Meet Philippa

Ever wondered what a #LucidLife looks like?Philippa McClure, Senior Account Director, takes us through her day. We have a number of roles in client services, just like Philippa's.So, if you like what...

My Journey into Medical Writing #LucidLife

In NetworkPharma’s latest career guide for wannabe medical writers, Jane Juif, Medical Writer, discusses her unconventional journey into the world of medical communications and medical writing.My journey into Med Comms...

LUCID GROUP PARTNERS WITH NEW INVESTOR ICG

Lucid Group has secured a new investment from Intermediate Capital Group (ICG) to support its continued ambition to build a global business that delivers life transforming value for everyone.Founded in...

IWD2021: #ChooseToChallenge Interview with Dennis O’Brien, Lucid Group CEO

Hey Dennis, what does this year’s IWD slogan, #ChooseToChallenge mean to you?I love it. It’s inspirational and action-oriented. It’s clear we need to change many things in our society, inequality...

Rare Disease Day in a COVID-19 environment

For many people and families living with a rare disease, their journey can be very complex. At times, that journey can even be scary, frustrating and confusing. However, when your...

We Celebrate Your Whole Selves: That’s What Makes The Magic

People are at the heart of who we are. Our aim is to transform the lives of those we touch without prejudice or discrimination. At Lucid, the magic we create...

Lucid Group: A Community of Purpose

In this month’s Pharmaceutical Marketing Europe, Lucid Group’s Chief People Officer, Angela Young, discusses the importance of bringing the company’s purpose to life so that its people feel connected to...

A magic milestone: Katherine’s 10-year workiversary

Katherine Duxbury recently celebrated the momentous and magical milestone of 10 years with Lucid Group – congratulations! Surprise virtual celebrations have been had and, while they were no replacement for...

Lucid Group – Let’s Start Talking

We can all help to transform the lives of those we touch by taking the time to talk and listen to one another. The power of conversation, sharing thoughts, worries...